Treatment agents for inhibiting HIV and cancer in HIV infected patients
US11364242B2 · kind B2 · utility
0Cited by
0References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 24, 2019 |
| Grant date | Jun 21, 2022 |
| Priority date | — |
| Expiry date | Sep 24, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods are provided for treating HIV and cancer in a subject in need thereof by administering to the subject therapeutically effective amounts of an mTOR inhibitor. Other methods are provided for treating subjects infected with HIV by administering to the subject therapeutically effective amounts of the mTOR inhibitor INK128, GSK2126458, AZD2014 or Torin-2.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.